Source Legend
- Human-provided
Entered or confirmed by an authorized person.
- Google
Imported Google information.
- Trial-derived
Calculated or extracted directly from associated trial records.
- AI-inferred
A capability inferred from trial history.
- AI-extracted
An explicit statement extracted from an official source.
- Public registry
Information from a public registry.
- Site record
Information held in the site record.
Source: Site record. START Midwest
Claim This Site
Are you the site administrator? Claim this site to update information.
Basic Information
Site Overview
South Texas Accelerated Research Therapeutics (START) Midwest is a drug development program and clinical trials center based in Grand Rapids, Michigan, established to bring cutting-edge cancer research directly to patients in West Michigan. WWMT It was formed through a partnership between the Cancer and Hematology Centers of Western Michigan (CHCWM) and San Antonio-based START, operating as part of START's global network of Phase I oncology research sites. Crain's Grand Rapids Business START Midwest gives Cancer and Hematology Centers patients first-ever access to experimental treatments and therapies, with Phase I trials led by physicians Dr. Nehal Lakhani, Dr. Manish Sharma, and Dr. Sreenivasa Chandana. CHC A key focus of the program is genomic testing, which identifies gene alterations in a patient's tumor to help guide targeted therapeutic development. WWMT The site is located at 5800 Foremost Drive, Grand Rapids, and is active across numerous cancer types, including…
Business Status
Business Category
Business Subcategory
Affiliations
Associated Organizations
Conditions
Sponsors
Accessibility & Parking
Accessibility Features